卫生系统药学推荐质量指标:2019年药学责任指标工作组更新
药学责任指标工作组从国家质量论坛质量定位系统中筛选与药物相关的已认可指标,经主题专家小组按预定排名系统评审并公开评论后,最终确定28项指标,涵盖抗血栓安全、心血管控制、血糖控制、疼痛管理、行为健康和抗菌药物管理六大治疗类别,旨在帮助药学部门在价值支付模式下展示问责与绩效。
要点
- 从656项已认可药物相关指标中经专家评审确定28项药学可问责质量指标。
- 指标覆盖抗血栓安全、心血管控制、血糖控制、疼痛管理、行为健康和抗菌药物管理六大类。
- 药学部门可借助这些指标在价值支付模式下展示绩效与药学服务价值。
核心结论
- 了解公开报告项目中可用的已认可质量指标,为药师展示绩效问责、改善质量与安全并提供护理价值证明创造机会。
研究设计与样本
- 药学责任指标工作组查询国家质量论坛质量定位系统中已认可的药物相关指标,经主题专家小组按预定排名系统评审并公开评论后确定纳入指标。
主要发现
- 国家质量论坛质量定位系统收录超过1000项指标,其中656项为已认可且与药物使用相关或受药物管理服务影响。
- 单一评审者将140项指标按治疗类别分类供主题专家评审,其余指标与上述临床领域无关。
- 主题专家小组最终确定28项指标纳入。
关键数值与推荐
- 纳入指标分为6个治疗类别:抗血栓安全、心血管控制、血糖控制、疼痛管理、行为健康和抗菌药物管理。
临床怎么用
- 药学部门可参照这28项指标明确可问责的质量领域,在价值支付模式下展示绩效改进与药学服务价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pharmacists are accountable for medication-related services provided to patients. As payment models transition from reimbursement for volume to reimbursement for value, pharmacy departments must demonstrate improvements in patient care outcomes and quality measure performance. The transition begins with an awareness of quality measures for which pharmacists and pharmacy personnel can demonstrate accountability across the continuum of care. The objective of the Pharmacy Accountability Measures (PAM) Work Group is to identify measures for which pharmacy departments can and should assume accountability. SUMMARY: The National Quality Forum (NQF) Quality Positioning System (QPS) was queried for NQF-endorsed medication-related measures. Included measures were curated into a data set of 6 therapeutic categories: antithrombotic safety, cardiovascular control, glucose control, pain management, behavioral health, and antimicrobial stewardship. Subject matter expert (SME) panels assigned to each area analyzed each measure according to a predetermined ranking system developed by the PAM Work Group. Measures remaining after SME review were disseminated during a public comment period for review and ballot. Over 1,000 measures are captured in the NQF QPS; 656 of the measures were found to be endorsed and medication use related or impacted by medication management services. A single reviewer categorized 140 measures into therapeutic categories for SME review; the remaining measures were unrelated to those clinical domains. The SME groups identified 28 measures for inclusion. CONCLUSION: An understanding of the endorsed quality measures available for public reporting programs provides an opportunity for pharmacists to demonstrate accountability for performance, thus improving quality and safety and demonstrating value of care provided.
引用
- Andrawis M, Ellison LTCC, Riddle S, et al. Recommended quality measures for health-system pharmacy: 2019 update from the Pharmacy Accountability Measures Work Group. Am J Health Syst Pharm. 2019. PMID: 31361855. doi:10.1093/ajhp/zxz069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。